SCHEMBL10358136

SCHEMBL10358136

Cc1ccc(O)c(-c2cc(-c3cc(Cl)ccc3C(F)(F)F)n[nH]2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 14/20 0.55
KMT2A Q03164 15/20 0.54
MAPT P10636 13/20 0.54
MEN1 O00255 13/20 0.54
ALOX15 P16050 8/20 0.54
LMNA P02545 6/20 0.54
NPSR1 Q6W5P4 5/20 0.54
MAPK1 P28482 2/20 0.54
SMN1; SMN2 Q16637 6/20 0.54
CASP3 P42574 2/20 0.54
SENP8 Q96LD8 2/20 0.54
SENP7 Q9BQF6 2/20 0.54
SENP6 Q9GZR1 2/20 0.54
POLB P06746 1/20 0.54
USP2 O75604 2/20 0.53
HSP90AA1 P07900 2/20 0.52
RAB9A P51151 7/20 0.51
ALDH1A1 P00352 4/20 0.51
NFKB1 P19838 2/20 0.51
NFKB2 Q00653 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7995433 0.85 HPGD (0.69) HPGDKMT2AMAPTMEN1ALOX15
SCHEMBL10376281 0.84 MAPT (0.67) HPGDKMT2AMAPTMEN1ALOX15
SCHEMBL10358273 0.81 ALOX15 (0.63) HPGDKMT2AMAPTMEN1ALOX15
SCHEMBL10358485 0.80 MAPT (0.61) HPGDKMT2AMAPTMEN1ALOX15
SCHEMBL10358589 0.76 HPGD (0.64) HPGDKMT2AMAPTMEN1ALOX15
SCHEMBL10358138 0.76 KMT2A (0.59) HPGDKMT2AMAPTMEN1ALOX15
SCHEMBL10358117 0.75 HPGD (0.56) HPGDKMT2AMAPTMEN1ALOX15
SCHEMBL10357278 0.75 HPGD (0.56) HPGDKMT2AMAPTMEN1ALOX15
SCHEMBL10357745 0.75 MEN1 (0.64) HPGDKMT2AMAPTMEN1ALOX15
SCHEMBL10357395 0.75 MAPT (0.68) HPGDKMT2AMAPTMEN1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120184583-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-07-19 US disclosed
US-20120184583-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-07-19 US disclosed
US-20100144798-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-06-10 US disclosed
US-20100144798-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184583-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 HPGD 1340/4885KMT2A 4334/4885MAPT 4385/4885
US-20100144798-A1 Modulators of ATP-Binding Cassette Transporters CFTR, ABCB1, ABCC2 HPGD 1340/4885KMT2A 4334/4885MAPT 4385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.